Grossman SJ - Search Results

1

Studies on the mechanism of simvastatin-induced thyroid hypertrophy and follicular cell adenoma in the rat.

Smith PF, Grossman SJ, Gerson RJ, Gordon LR, Deluca JG, Majka JA, Wang RW, Germershausen JI, MacDonald JS. Smith PF, et al. Among authors: grossman sj. Toxicol Pathol. 1991;19(3):197-205. doi: 10.1177/019262339101900301. Toxicol Pathol. 1991. PMID: 1780636

2

HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.

Smith PF, Eydelloth RS, Grossman SJ, Stubbs RJ, Schwartz MS, Germershausen JI, Vyas KP, Kari PH, MacDonald JS. Smith PF, et al. Among authors: grossman sj. J Pharmacol Exp Ther. 1991 Jun;257(3):1225-35. J Pharmacol Exp Ther. 1991. PMID: 1904494

3

Enantioselective induction of peroxisomal proliferation in CD-1 mice by leukotriene antagonists.

Grossman SJ, DeLuca JG, Zamboni RJ, Keenan KP, Patrick DH, Herold EG, van Zwieten MJ, Zacchei AG. Grossman SJ, et al. Toxicol Appl Pharmacol. 1992 Oct;116(2):217-24. doi: 10.1016/0041-008x(92)90301-8. Toxicol Appl Pharmacol. 1992. PMID: 1412466

4

Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate.

Tanaka K, Smith PF, Stromberg PC, Eydelloth RS, Herold EG, Grossman SJ, Frank JD, Hertzog PR, Soper KA, Keenan KP. Tanaka K, et al. Among authors: grossman sj. Toxicol Appl Pharmacol. 1992 Sep;116(1):71-7. doi: 10.1016/0041-008x(92)90146-j. Toxicol Appl Pharmacol. 1992. PMID: 1529455

5

Myopathy associated with HMG-CoA reductase inhibitors (HMGRIs) and cyclosporin A: evaluation in a rat model.

Smith PF, Eydelloth RS, Grossman SJ, Stubbs RJ, Schwartz MS, Germershausen JI, MacDonald JS. Smith PF, et al. Among authors: grossman sj. Eur Heart J. 1992 Jul;13 Suppl B:2-6. doi: 10.1093/eurheartj/13.suppl_b.2. Eur Heart J. 1992. PMID: 1644096 No abstract available.

6

Thiobenzamide-induced hepatotoxicity: effects of substituents and route of administration on the nature and extent of liver injury.

Grossman SJ, Patrick DH, Kornbrust D, Smith PF, Herold EG, DeLuca JG, Zacchei AG. Grossman SJ, et al. Toxicol Appl Pharmacol. 1991 Dec;111(3):388-408. doi: 10.1016/0041-008x(91)90245-a. Toxicol Appl Pharmacol. 1991. PMID: 1746022

7

External genitalia abnormalities in male rats exposed in utero to finasteride, a 5 alpha-reductase inhibitor.

Clark RL, Antonello JM, Grossman SJ, Wise LD, Anderson C, Bagdon WJ, Prahalada S, MacDonald JS, Robertson RT. Clark RL, et al. Among authors: grossman sj. Teratology. 1990 Jul;42(1):91-100. doi: 10.1002/tera.1420420111. Teratology. 1990. PMID: 2168096

8

Hepatotoxicity of an HIV protease inhibitor in dogs and rats.

Grossman SJ, Reinford N, Anderson C, Eydelloth RS, Alberts DW, Smith PF, Patrick DH. Grossman SJ, et al. Toxicol Appl Pharmacol. 1997 Sep;146(1):40-52. doi: 10.1006/taap.1997.8224. Toxicol Appl Pharmacol. 1997. PMID: 9299595

9

Drug metabolites in safety testing.

Baillie TA, Cayen MN, Fouda H, Gerson RJ, Green JD, Grossman SJ, Klunk LJ, LeBlanc B, Perkins DG, Shipley LA. Baillie TA, et al. Among authors: grossman sj. Toxicol Appl Pharmacol. 2002 Aug 1;182(3):188-96. doi: 10.1006/taap.2002.9440. Toxicol Appl Pharmacol. 2002. PMID: 12229863 Review.

10

Morphological and hormonal changes in the ventral and dorsolateral prostatic lobes of rats treated with finasteride, a 5-alpha reductase inhibitor.

Prahalada S, Rhodes L, Grossman SJ, Heggan D, Keenan KP, Cukierski MA, Hoe CM, Berman C, van Zwieten MJ. Prahalada S, et al. Among authors: grossman sj. Prostate. 1998 May 15;35(3):157-64. doi: 10.1002/(sici)1097-0045(19980515)35:3<157::aid-pros1>3.0.co;2-e. Prostate. 1998. PMID: 9582084

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters